Unveiling the Invisible
Bioanalysis is the science of revealing the unseen, transforming data into medicines that change lives. We leverage the synergy of three harmonized labs to unveil bold, innovative bioanalytical solutions to support both preclinical and clinical studies at our facilities, in addition to offering an extensive standalone solution to meet the diverse needs of clients.
Altasciences’ Unveiling the Invisible video campaign showcases how these solutions can provide critical insights that unveil the invisible and drive the creation of innovative therapies.
unveiling the invisible: Dna
A single nucleotide is the building block for every living thing. Similarly, bioanalysis is the building block to life-changing therapies. At Altasciences, we’re pushing the boundaries, transforming the seemingly insignificant into groundbreaking discoveries.
UNVEILING THE INVISIBLE: H20
A single water molecule may seem insignificant on its own, but it can transform the world. At Altasciences, bioanalysis is the science of revealing the unseen, transforming data into medicines that change lives. We leverage the synergy of three harmonized labs to unveil bold, innovative bioanalytical solutions. Behind every safe and effective drug is the power of bioanalysis.
UNVEILING THE INVISIBLE: SYNAPSE
Just as a single synapse plays a vital role in the nervous system, and the smallest details can make the most significant differences in drug development—bioanalysis brings those details to light, maximizing every drug's potential. Through constant communication and collaboration, our scientists unveil the secrets of tiny molecules that bring hope to patients worldwide.
At Altasciences, we’re transforming the seemingly insignificant into groundbreaking discoveries, helping sponsors get better drugs to the people who need them, faster.
ABOUT ALTASCIENCES’ BIOANALYTICAL SOLUTions
From discovery to Phase IV, we excel in providing comprehensive bioanalytical services, including assay and method development, molecular biology, mass spectrometry, ligand binding assays (LBA), immunogenicity testing, biomarker analysis, microsampling, flow cytometry services, and more, supporting your journey from discovery through Phase IV.
Strategically located for integrated service delivery, we focus on delivering quality data for TK, PK, and PD analyses, critical for preclinical and clinical study success.
